ReviewAnnals of surgical treatment and research2026
Cutting-edge trends in da Vinci single-port robotic approaches to breast surgery: a narrative review.
Review in Annals of surgical treatment and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The da Vinci single-port (SP) platform (Intuitive Surgical, Inc.) has catalyzed a new phase of remote-access breast surgery by delivering multi-jointed, wristed instrumentation and stable 3-dimensional optics through a single trocar. This narrative review synthesizes contemporary evidence and practice patterns for SP-assisted procedures, drawing on a recent series of robotic nipple-sparing mastectomies (NSMs). Indications parallel conventional NSM with patient selection favoring small-to-moderate breasts and tumors distant from the nipple-areolar complex; formal contraindications largely mirror those of open techniques. SP kinematic features, such as cobra wrist configurations, diminish the blind spots typical of multiport approaches, and the SP system's combined multi-image display supports real-time imaging overlays that help maintain uniform flap thickness. Across comparative cohorts, overall postoperative complication rates with robotic approaches do not differ significantly from conventional NSM. Oncologic follow-up remains limited, underscoring the need for longer surveillance to establish non-inferiority. Cosmesis and patient satisfaction are consistently superior due to hidden incisions and improved contour. Unique risks demand caution, notably skin-flap ischemia/necrosis, as well as the opposite risk of residual tissue when flaps are made too thick. Safe adoption depends on structured training that includes device familiarization, team-based drills, high-fidelity simulation, and staged proctoring. Recognition of a learning curve characterized by substantial reductions in operative time was found across initial cases. Critical priorities are prospective, controlled trials of oncologic outcomes, standardized frameworks for credentialing and competency, and comprehensive cost-effectiveness evaluations. With disciplined case selection, standardized flap assessment, and team-based training, SP robotic breast surgery achieves concealed-scar cosmesis while maintaining core oncologic principles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.